Boston Scientific (BSX)$57.78
Market Cap: 154.18 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Boston Scientific (BSX).
HEALTHCARE
MEDICAL DEVICES
DCF ready
Valuation
41.6x
EV/FCF, 2.4% FCF yield
Quality
11.9%
ROIC, 18.2% FCF margin
Growth
15.2%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 1.6x current ratio
Superinvestors
5
Top: Lee Ainslie (3.1%)
Strengths to research
- Revenue compounded at 15.2% over five years.
- Free cash flow compounded at 26.4% over five years.
- Free cash flow margin is healthy at 18.2%.
- Debt/equity looks manageable at 0.0x.
Watchouts
- P/FCF is elevated at 42.1x.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for BSX.
Grade C
62
/ 100
Peer Comparison
Target stock against 6 market-cap comparable peers.
Heat map: red worst to green best
| BSX Target | Boston Scientific | $154.2B | 29.8x | 41.6x | 11.9% | 15.2% | 18.2% | 69.0% | -0.4x | N/A |
| SYK | Stryker Corp. | $145.6B | 37.7x | 33.0x | 14.5% | 11.8% | 17.1% | 64.0% | -0.6x | N/A |
| MDT | Medtronic plc | $107.0B | 21.8x | 20.2x | 9.7% | 3.0% | 15.5% | N/A | -0.3x | N/A |
| ABT | Abbott Labs | $230.7B | 23.5x | 31.8x | 10.0% | 5.1% | 16.7% | N/A | 0.5x | N/A |
| EW | Edwards Lifesciences Corp. | $44.0B | 46.9x | 30.8x | 10.4% | 6.7% | 22.0% | 78.0% | -2.1x | N/A |
| DXCM | DEXCOM, INC. | $31.5B | 34.5x | 28.4x | 30.5% | 19.3% | 23.1% | 60.1% | -0.8x | N/A |
| STE | STERIS plc | $22.0B | 34.9x | 30.6x | 7.2% | 12.5% | 14.3% | 44.0% | 1.3x | N/A |
Financial Charts
No financial data available for BSX (annual).
5 superinvestors own BSX
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Lee Ainslie Maverick Capital | 4,195,089 | $263M | 3.06% | 0.0% |
| Polen Capital Management Polen Capital Management | 579,739 | $36M | 0.25% | 0.0% |
| Stephen Mandel Lone Pine Capital | 104,655 | $7M | 0.05% | 0.0% |
| Dodge & Cox Dodge & Cox | 88,885 | $6M | 0.00% | 0.0% |
| Mairs & Power Growth Fund Mairs & Power Growth Fund | 10,176 | $639,000 | 0.01% | 0.0% |